Clinical Trial Update: Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dexamethasone as adjunctive therapy to ranibizumab for choroidal neovascularization in age-related macular degeneration. The study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Allergan | Conditions: Subfoveal Choroidal Neovascularization, Age-Related Maculopathy | Phase 2 | Status: TERMINATED | Results posted: 2012-09-05